Pharmaniaga Berhad (PHARMA):企業の財務・戦略的SWOT分析

◆英語タイトル:Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2726
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,875見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Pharmaniaga Berhad (PHARMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pharmaniaga Berhad (Pharmaniaga), a member of Boustead Group is an investment holding company. It is an integrated pharmaceutical group that operates across a wide spectrum of the healthcare industry through its subsidiaries. The company carries out logistics and distribution and manufacturing of generic pharmaceuticals; and sales, marketing and distribution of medical products and hospital equipment. Pharmaniaga also operates community pharmacies in Malaysia; and provides pharmaceutical products, diagnostic products and food supplements in Indonesia. The company has manufacturing facilities and logistics and distribution warehouses in Malaysia and Indonesia; and operates across Malaysia, Indonesia, Vietnam and the US. Pharmaniaga is headquartered at Shah Alam in Selangor, Malaysia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Pharmaniaga Berhad – Key Facts 6
Pharmaniaga Berhad – Key Employees 7
Pharmaniaga Berhad – Key Employee Biographies 8
Pharmaniaga Berhad – Major Products and Services 9
Pharmaniaga Berhad – History 10
Pharmaniaga Berhad – Company Statement 12
Pharmaniaga Berhad – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Pharmaniaga Berhad – Business Description 16
Business Segment: Indonesia 16
Overview 16
Performance 16
Business Segment: Logistics and Distribution 16
Overview 16
Performance 16
Business Segment: Manufacturing 16
Overview 16
Performance 17
Geographical Segment: Indonesia 17
Performance 17
Geographical Segment: Malaysia 17
Performance 17
Geographical Segment: Other countries 17
Performance 17
Pharmaniaga Berhad – Corporate Strategy 18
Pharmaniaga Berhad – SWOT Analysis 19
SWOT Analysis – Overview 19
Pharmaniaga Berhad – Strengths 19
Pharmaniaga Berhad – Weaknesses 20
Pharmaniaga Berhad – Opportunities 21
Pharmaniaga Berhad – Threats 22
Pharmaniaga Berhad – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Pharmaniaga Berhad, Recent Deals Summary 33
Section 5 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Pharmaniaga Berhad, Key Facts 6
Pharmaniaga Berhad, Key Employees 7
Pharmaniaga Berhad, Key Employee Biographies 8
Pharmaniaga Berhad, Major Products and Services 9
Pharmaniaga Berhad, History 10
Pharmaniaga Berhad, Subsidiaries 14
Pharmaniaga Berhad, Key Competitors 23
Pharmaniaga Berhad, Ratios based on current share price 24
Pharmaniaga Berhad, Annual Ratios 25
Pharmaniaga Berhad, Annual Ratios (Cont...1) 26
Pharmaniaga Berhad, Annual Ratios (Cont...2) 27
Pharmaniaga Berhad, Interim Ratios 29
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Pharmaniaga Berhad, Recent Deals Summary 33
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Pharmaniaga Berhad, Performance Chart (2013 - 2017) 28
Pharmaniaga Berhad, Ratio Charts 30
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

★海外企業調査レポート[Pharmaniaga Berhad (PHARMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Foundation Medicine Inc (FMI)-製薬・医療分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Ambuja Cements Limited:企業の戦略・SWOT・財務情報
    Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report Summary Ambuja Cements Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Steel Authority of India Ltd:企業の戦略・SWOT・財務情報
    Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Imperial College London:企業のM&A・事業提携・投資動向
    Imperial College London - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imperial College London Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Suntory Holdings Ltd:戦略・SWOT・企業財務分析
    Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Fuller, Smith & Turner Plc:企業の戦略・SWOT・財務情報
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vectura Group Plc (VEC)-医療機器分野:企業M&A・提携分析
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …
  • Scb Life Assurance Public Company Limited
    Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Equinix Inc (EQIX):企業の財務・戦略的SWOT分析
    Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析
    Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • GIZEH Raucherbedarf GmbH:企業の戦略的SWOT分析
    GIZEH Raucherbedarf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ImaBiotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that provides mass spectrometry imaging services. The organization offers software products such as multimaging and quantinetix. Its service portfolio includes consulting and training, biomarker discovery, pharmaco-kinetics and …
  • Maharashtra State Power Generation Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Maharashtra State Power Generation Co., Ltd. (Mahagenco) is a state government-owned electricity company. The company generates and supplies electricity across the state of Maharashtra, India. Mahagenco owns and operates generation facilities, and uses diverse fuel sources such as thermal, g …
  • Ultragenyx Pharmaceutical Inc.:企業の戦略・SWOT・財務分析
    Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Abg Sundal Collier Holding Asa
    Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report Summary Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Fluor Corporation (FLR)-エネルギー分野:企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • PZU SA:企業の戦略・SWOT・財務情報
    PZU SA - Strategy, SWOT and Corporate Finance Report Summary PZU SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆